CHEMINFORMATICS.ORG
Today's Pharma Headlines: Pfizer announces outcome of FDA's ODAC meeting for SUTENT in patients at high risk of recurrent renal cell carcinoma after surgery - Ipsen gets EC approval for Xermelo to treat carcinoid syndrome diarrhea - GSK, Innoviva get FDA nod for COPD treatment Trelegy Ellipta - ...